These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

93 related items for PubMed ID: 6150750

  • 1. Primate model of Parkinson's disease: alterations in multiple opioid systems in the basal ganglia.
    Zamir N, Skofitsch G, Bannon MJ, Helke CJ, Kopin IJ, Jacobowitz DM.
    Brain Res; 1984 Nov 26; 322(2):356-60. PubMed ID: 6150750
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Peptides derived from prodynorphin are decreased in basal ganglia of Huntington's disease brains.
    Dawbarn D, Zamir N, Waters CM, Hunt SP, Emson PC, Brownstein MJ.
    Brain Res; 1986 Apr 30; 372(1):155-8. PubMed ID: 2871898
    [Abstract] [Full Text] [Related]

  • 5. Immunohistochemical evidence for different opioid systems in the rat superior cervical ganglion as revealed by imipramine treatment and receptor blockade.
    Folan JC, Heym C.
    J Chem Neuroanat; 1989 Apr 30; 2(2):107-18. PubMed ID: 2574980
    [Abstract] [Full Text] [Related]

  • 6. Proenkephalin and prodynorphin related neuropeptides in the cochlea.
    Hoffman DW, Zamir N, Rubio JA, Altschuler RA, Fex J.
    Hear Res; 1985 Jan 30; 17(1):47-50. PubMed ID: 2860094
    [Abstract] [Full Text] [Related]

  • 7. Chronic haloperidol and clozapine differentially affect dynorphin peptides and substance P in basal ganglia of the rat.
    Nylander I, Terenius L.
    Brain Res; 1986 Aug 13; 380(1):34-41. PubMed ID: 2428423
    [Abstract] [Full Text] [Related]

  • 8. Met-enkephalin-like and dynorphin-like immunoreactivities of the basal ganglia of the cat.
    Chesselet MF, Graybiel AM.
    Life Sci; 1983 Aug 13; 33 Suppl 1():37-40. PubMed ID: 6141495
    [Abstract] [Full Text] [Related]

  • 9. Immunocytochemical studies of substance P and Met-enkephalin in the basal ganglia and substantia nigra in Huntington's, Parkinson's and Alzheimer's diseases.
    Grafe MR, Forno LS, Eng LF.
    J Neuropathol Exp Neurol; 1985 Jan 13; 44(1):47-59. PubMed ID: 2578185
    [Abstract] [Full Text] [Related]

  • 10. [Experimental research on 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonian animal models in the rhesus monkey and C57 black mouse].
    Chen S.
    Zhonghua Yi Xue Za Zhi; 1990 May 13; 70(5):252-4, 18. PubMed ID: 2168792
    [Abstract] [Full Text] [Related]

  • 11. Alterations in peptide levels in Parkinson's disease and incidental Lewy body disease.
    Fernandez A, de Ceballos ML, Rose S, Jenner P, Marsden CD.
    Brain; 1996 Jun 13; 119 ( Pt 3)():823-30. PubMed ID: 8673494
    [Abstract] [Full Text] [Related]

  • 12. The comparison between enkephalin-like and dynorphin-like immunoreactivity in both monkey and human globus pallidus and substantia nigra.
    Haber SN, Watson SJ.
    Life Sci; 1983 Jun 13; 33 Suppl 1():33-6. PubMed ID: 6141493
    [Abstract] [Full Text] [Related]

  • 13. Characterization of proenkephalin B-derived opioid peptides in the human hypothalamo-neurohypophyseal axis.
    Arendt RM, Seizinger BR, Pasi A, Mehraein P, Herz A.
    Brain Res; 1985 Oct 21; 345(2):230-7. PubMed ID: 2864112
    [Abstract] [Full Text] [Related]

  • 14. Lack of change in basal ganglia neuropeptide content following subacute 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine treatment of the common marmoset.
    Jenner P, Taquet H, Mauborgne A, Benoliel JT, Cesselin F, Rose S, Javoy-Agid F, Agid Y, Marsden CD.
    J Neurochem; 1986 Nov 21; 47(5):1548-51. PubMed ID: 2428937
    [Abstract] [Full Text] [Related]

  • 15. Endogenous opioid peptides in parasympathetic, sympathetic and sensory nerves in the guinea-pig heart.
    Steele PA, Aromataris EC, Riederer BM.
    Cell Tissue Res; 1996 May 21; 284(2):331-9. PubMed ID: 8625399
    [Abstract] [Full Text] [Related]

  • 16. Steady state levels of pro-dynorphin-related end products in the striatum and substantia nigra of the adult rhesus monkey.
    Dores RM, Akil H.
    Peptides; 1985 May 21; 6 Suppl 2():143-8. PubMed ID: 2867528
    [Abstract] [Full Text] [Related]

  • 17. Dynorphin- and enkephalin-like immunoreactivity is altered in limbic-basal ganglia regions of rat brain after repeated electroconvulsive shock.
    Kanamatsu T, McGinty JF, Mitchell CL, Hong JS.
    J Neurosci; 1986 Mar 21; 6(3):644-9. PubMed ID: 2870139
    [Abstract] [Full Text] [Related]

  • 18. Alterations in m-RNA expression for Cu,Zn-superoxide dismutase and glutathione peroxidase in the basal ganglia of MPTP-treated marmosets and patients with Parkinson's disease.
    Kunikowska G, Jenner P.
    Brain Res; 2003 Apr 11; 968(2):206-18. PubMed ID: 12663090
    [Abstract] [Full Text] [Related]

  • 19. Characterization and localization of immunoreactive dynorphin, alpha-neo-endorphin, Met-enkephalin and substance P in human spinal cord.
    Przewłocki R, Gramsch C, Pasi A, Herz A.
    Brain Res; 1983 Nov 28; 280(1):95-103. PubMed ID: 6197139
    [Abstract] [Full Text] [Related]

  • 20. The effects of morphine treatment and morphine withdrawal on the dynorphin and enkephalin systems in Sprague-Dawley rats.
    Nylander I, Vlaskovska M, Terenius L.
    Psychopharmacology (Berl); 1995 Apr 28; 118(4):391-400. PubMed ID: 7568625
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.